Atorvastatin Calcium
Product Images NDC 68071-2788

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2788). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2788 9)

NuCare Pharmaceuticals, Inc. is providing information about Atorvastatin Calcium 40mg tablets that are available in lots with NDC numbers 68071-2788-09 and 63097-1278-8. The tablets should be stored at controlled temperatures of 68-77°F and kept out of the reach of children. The label provides a warning to call a doctor for medical advice in case of side effects and also lists ingredients, but the expiration date is not available. The lot number is 00000, and there is a serial number for the tablets. Customers can report side effects to the FDA at the contact number provided on the label.*

FDA Label Image

Figure-01 (Figure 01)

This is a figure caption depicting a graph showing the effect of 10 mg/day of Atorvastatin Calcium on the cumulative incidence of non-fatal myocardial infarction or coronary heart disease death in ASCOT-LLA over a duration of 35 years. The graph shows a HR (Hazard Ratio) of 0.64 with a 95% CI (Confidence Interval) of 0.50 to 0.83 and a p-value of 0.0005. The remaining text appears to show the labels on the x-axis, y-axis, and legend of the graph and doesn't provide any additional information.*

FDA Label Image

Figure-02 (Figure 02)

This is a graph that shows the effect of taking Atorvastatin Calcium 10mg/day on the occurrence of major cardiovascular events (such as heart attack, stroke etc.) in a study called CARDS. The horizontal axis shows the time period up to 5 years and the vertical axis shows the cumulative hazard in percentage. The graph shows a decreased cumulative hazard in the group taking Atorvastatin Calcium. The Hazard Ratio (HR) is 0.63 which suggests a significant reduction in events in the group taking Atorvastatin Calcium.*

FDA Label Image

Figure-03 (Figure 03)

This is a figure showing the effect of two different dosages (80 mg/day and 10 mg/day) of Atorvastatin Calcium on the time it takes for major cardiovascular events to occur. The x-axis represents the time to the first major cardiovascular endpoint in years, and the y-axis represents the percentage of subjects experiencing the event. The data suggests that Atorvastatin Calcium 80 mg/day has a lower hazard ratio (HR=0.78) for major cardiovascular events compared to 10 mg/day (p=0.0002).*

FDA Label Image

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.